107.521 articles found

Walking ability after implantation of a pallidal stimulator: analysis of plantar force distribution in patients with Parkinson's disease.

Nieuwboer A, De Weerdt W, Dom R, Nuttin B, Peeraer L, Pattyn A.

Parkinsonism Relat Disord · 1998-12-01

DOI: 10.1016/s1353-8020(98)00038-8PMID: 18591110

Dispersible levodopa has a fast and more reproducible onset of action than the conventional preparation in Parkinson's disease. A study with optoelectronic movement analysis.

Jansson Y, Eriksson B, Johnels B.

Parkinsonism Relat Disord · 1998-12-01

DOI: 10.1016/s1353-8020(98)00036-4PMID: 18591111

Rare tendency of catching cold in Parkinson's disease.

Kawaguchi N, Yamada T, Hattori T.

Parkinsonism Relat Disord · 1998-12-01

DOI: 10.1016/s1353-8020(98)00035-2PMID: 18591112

Calcium channel blocker-induced parkinsonism: clinical features and comparisons with Parkinson's disease.

García-Ruiz PJ, Javier Jiménez-Jiménez F, García de Yébenes J.

Parkinsonism Relat Disord · 1998-12-01

DOI: 10.1016/s1353-8020(98)00032-7PMID: 18591113

Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms.

Yoshida K, Sugita T, Higuchi H, Hishikawa Y.

Eur Psychiatry · 1998-12-01

DOI: 10.1016/s0924-9338(99)80690-7PMID: 19698659

The role of serotonin in Parkinsons' Disease: An integrated approach for research of motor, cognitive and affective symptoms with functional intervention studies.

Leentjens AF, Verhey FR, Vreeling FW, van Praag HM.

Acta Neuropsychiatr · 1998-12-01

DOI: 10.1017/s0924270800036425PMID: 26971892

Sustained release compositions for nasal administration of drugs for treating erectile disfunction and parkinson's disease

ILLUM LISBETH, WATTS PETER JAMES.

· 1998-11-27

New variant forms of the human parkin gene, used as source of primers and probes for detecting susceptibility to Parkinson's disease

BRICE ALEXIS, LUCKING CHRISTOPHE, ABBAS NACER EDDINE, DENEFLE PATRICE, RICARD SYLVAIN, BOULEY SANDRINE.

· 1998-11-19

New nucleic acid for regulating gene expression, particularly expression of tyrosine hydroxylase for treatment of Parkinson's disease, includes the gene and tetracycline transactivator

MALLET JACQUES, CORTI OLGA.

· 1998-11-09

Use of nicotine patch for treating Parkinson's disease

BROSIG STEFAN.

· 1998-11-04

The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.

Biggs CS, Fisher A, Starr MS.

Synapse · 1998-11-01

DOI: 10.1002/(sici)1098-2396(199811)30:3<309::aid-syn8>3.0.co;2-fPMID: 9776134

Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.

Li H, Shen XM, Dryhurst G.

J Neurochem · 1998-11-01

DOI: 10.1046/j.1471-4159.1998.71052049.xPMID: 9798930